Reported Dec 6, 2023 · Ongoing

Indomethacin 25mg Capsules, USP, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd.…

Glenmark Pharmaceuticals Inc., USA

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Glenmark Pharmaceuticals Inc., USA · 750 Corporate Dr · Mahwah, NJ · 07430-2009

Is this the product you have?

  • Indomethacin 25mg Capsules, USP, 100-count bottle, Rx Only
  • Manufactured byGlenmark Pharmaceuticals Ltd. Colvale-Bardez, Goa 403513, India
  • Manufactured forGlenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-406-01
Lot codes and dates
    • Lot# 19231903
    • Exp 4/2025 Lot# 19231858
    • Exp 4/2025 Lot# 19231881
    • Exp 4/2025 Lot# 19233484
    • Exp 8/2025 Lot# 19233490
    • Exp 8/2025
Amount recalled
37,200 bottles

This recall covers 2 products

The agency filed one notice per product. You are reading one of them; the other one is below.

Where it was sold

  • Nationwide

Why it was recalled

Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Glenmark Pharmaceuticals Inc., USA recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Data as of Sep 19, 7:22 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.